Biophytis S.A. (ALBPS) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.472x

Based on the latest financial reports, Biophytis S.A. (ALBPS) has a cash flow conversion efficiency ratio of 0.472x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-3.69 Million ≈ $-4.32 Million USD) by net assets (€-7.82 Million ≈ $-9.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biophytis S.A. defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Biophytis S.A. - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Biophytis S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biophytis S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biophytis S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanti Overseas (India) Limited NSE:SHANTI	-0.015x
Crystal Amber Fund Limited LSE:CRS	-0.003x
First Tin PLC LSE:1SN	-0.028x
Omkar Speciality Chemicals Limited NSE:OMKARCHEM	-0.005x
Kodal Minerals PLC LSE:KOD	0.000x
Eco Animal Health Group Plc LSE:EAH	-0.011x
Calnex Solutions Plc LSE:CLX	0.111x
BLUEBIRD MERCH.VENT. LTD. F:09D	N/A

Annual Cash Flow Conversion Efficiency for Biophytis S.A. (2013–2024)

The table below shows the annual cash flow conversion efficiency of Biophytis S.A. from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see ALBPS market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	€-9.70 Million ≈ $-11.34 Million	€-8.64 Million ≈ $-10.10 Million	0.891x	-73.09%
2023-12-31	€-3.89 Million ≈ $-4.55 Million	€-12.87 Million ≈ $-15.05 Million	3.310x	-66.69%
2022-12-31	€-1.91 Million ≈ $-2.23 Million	€-18.99 Million ≈ $-22.20 Million	9.936x	+338.23%
2021-12-31	€5.71 Million ≈ $6.67 Million	€-23.80 Million ≈ $-27.82 Million	-4.171x	-188.88%
2020-12-31	€6.83 Million ≈ $7.99 Million	€-9.86 Million ≈ $-11.53 Million	-1.444x	-171.15%
2019-12-31	€-7.53 Million ≈ $-8.80 Million	€-15.27 Million ≈ $-17.86 Million	2.029x	+217.92%
2018-12-31	€7.01 Million ≈ $8.19 Million	€-12.06 Million ≈ $-14.10 Million	-1.721x	-317.79%
2017-12-31	€21.19 Million ≈ $24.77 Million	€-8.73 Million ≈ $-10.20 Million	-0.412x	+71.94%
2016-12-31	€4.52 Million ≈ $5.28 Million	€-6.63 Million ≈ $-7.75 Million	-1.468x	-433.55%
2015-12-31	€11.67 Million ≈ $13.64 Million	€-3.21 Million ≈ $-3.75 Million	-0.275x	-147.13%
2014-12-31	€-1.13 Million ≈ $-1.32 Million	€-658.89K ≈ $-770.31K	0.584x	-70.26%
2013-12-31	€-409.32K ≈ $-478.54K	€-803.29K ≈ $-939.14K	1.962x	--

About Biophytis S.A.

PA:ALBPS France Biotechnology

Market Cap

$752.91K

€644.00K EUR

Market Cap Rank

#30647 Global

#578 in France

Share Price

€0.02

Change (1 day)

+0.00%

52-Week Range

€0.02 - €0.20

All Time High

€4896.00